References
- DE MORAIS, S. M. F., WILKINSON, G. R., BLAISDELL, J., MEYER, U. A., NAKAMURA, K. and GOLDSTEIN, J. A., 1994a, Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Molecular Pharmacology, 46, 594–598.
- DE MORAIS, S. M. F., WILKINSON, G. R., BLAISDELL, J., NAKAMURA, K., MEYER, U. A. and GOLDSTEIN, J. A., 1994b, The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. Journal of Biological Chemistry, 269, 15419–15422.
- FURUYA, H., MEYER, U. A., GELBOIN, H. V. and GONZALEZ, F. J., 1991, Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA. Molecular Pharmacology, 40, 375–382.
- GED, C. and BEAUNE, P., 1992, Partial sequence and polymerase chain reaction-mediated analysis of expression of the human CYP2C18 gene. Pharmacogenetics, 2, 109–115.
- GOLDSTEIN, J. A. and DE MORAIS, S. M. F., 1994, Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics, 4, 285–299.
- GONZALEZ, F. J., 1989, The molecular biology of cytochrome P450s. Pharmacological Reviews, 40, 243–288.
- GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
- IBEANCT, G. C. and GOLDSTEIN, J. A., 1995, Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry, 34, 8028–8036.
- INOUE, K., INAZAWA, J., SUZUKI, Y., SHEVIADA, T., YAMAZAKI, H., GUENGERICH, F. P. and ABE, T., 1994, Fluorescence in situ hybridization analysis of chromosomal localization of three human cytochrome P450 2C genes (CYP2C8, 2C9, and 2C10) at 10q24.1. Japanese Journal of Human Genetics, 39, 337–343.
- INOUE, K., YAMAZAKI, H., ImIYA, K., AKASAKA, S., GUENGERICH, F. P. and SHIMADA, T., 1997, Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. Pharmacogenetics, 7, 103–113.
- KOMAI, K., SUMIDA, K., KANEKO, H. and NAKATSUKA I., 1996, Identification of a new non-functional CYP2C18 allele in Japanese: substitution of T204 to A in exon2 generates a premature stop codon. Pharmacogenetics, 6, 117–119.
- MEEHAN, R. R., GOSDEN, J. R., ROUT, D., HASTIE, N. D., FRIEDBERG, T., ADESNIK, M., BUCKLAND, R., HEYNINGEN, V. V., FLETCHER, J., SPURR, N. K., SWEENEY, J. and WOLF, C. R., 1988, Human cytochrome P-450 PB-1: A multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. American Journal of Human Genetics, 42, 26–37.
- NEBERT, D. W. AND GONZALEZ, F. J., 1987, P450 genes: structure, evolution, and regulation. Annual Reviews of Biochemistry, 56, 945–993.
- NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., FSTABROOK, R. W., GUNSALUS I. C. and NEBERT D. W., 1996, P450 superfamily : update on new sequences, gene mapping, accession numbers and nomenclature. Phamaco genetics, 6, 1–42.
- RICHARDSON, T. H., GRIFFIN, K. J., JUNG, F. J., RAUCY, J. L. and JOHNSON, E. F., 1997, Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C5. Archives of Biochemistry and Biophysics, 338, 157–164.
- ROMKES M., FALETTO, M. B., BLAISDELL, J. A., RAUCY, J. L. and GOLDSTEIN, J. A., 1991, Cloning and expression of complementary DNAs for multiple members of the human cytochrome P4501IC subfamily. Biochemistry, 30, 3247–3255.
- SHIMADA, T., MISONO, K. S. and GUENGERICH, F. P., 1986, Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. Journal of Biological Chemistry, 261, 909–921.
- SHIMADA T., YAMAZAKI, H., MIMURA M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
- TSUNEOKA, Y., MATSUO, Y., OKUYAMA, E., WATANABE, Y. and ICHIKAWA, Y., 1996, Genetic analysis of the cytochrome P-450I1C18 (CYP2C18) gene and a novel member of the CYP2C subfamily. FEBS Letters, 384, 281–284.
- WANG, S. L., HUANG, J. D., LAI, M. D. and TSAI, J. J., 1995, Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese. Pharmaco genetics, 5, 37–42.
- YAMAZAKI, H., INouE, K., TURVY, C. G., GUENGERICH, F. P. and SHIMADA, T., 1997, Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Drug Metabolism and Disposition, 25, 168–174.
- ZAPHIROPOULOS, P. G., 1997, Exon skipping and circular RNA formation in transcripts of the human cytochrome P450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis. Molecular and Cellular Biology, 17, 2985–2993.